Omrix Biopharmaceuticals develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets.
Business Model:
Revenue: $0
Employees: 501-1,000
Omrix Biopharmaceuticals was acquired by
Johnson &a; Johnson.
The acquisition happend on 2008-11-23.
Details of the transaction were not public
Address:
City: Qiryat Ono
State: Tel Aviv
Zip:
Country: Israel
Omrix Biopharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
4/21/2006
Ticker Symbol:
OMRI
Amount Raised:
$34M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2007 | Post-IPO Equity | 1 | - |
Thuja Capital Thuja Capital |
4/1999 | Venture Round | 1 | $20M |
MPM Capital MPM Capital |
2/2005 | Series A | 1 | $1.6M |
Catalyst Fund LP Catalyst Fund LP |
3/2005 | Venture Round | 1 | $4.8M |
Hercules Capital Hercules Capital |
2/2007 | Post-IPO Equity | 1 | - |
Thuja Capital Thuja Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|